IMPACTfolio’s AbbVie ABBV Stock Holding History

IMPACTfolio’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$461K	Hold	1,761	–	–	0.17%	23
2026 Q2	$443K	Hold	1,761	–	–	0.17%	23
2026 Q1	$383K	Sell	1,761 -345	-16%	-$76.5K	0.16%	22
2025 Q4	$481K	Hold	2,106	–	–	0.2%	20
2025 Q3	$488K	Buy	2,106 +790	+60%	+$161K	0.21%	22
2025 Q2	$244K	Hold	1,316	–	–	0.12%	28
2025 Q1	$276K	Hold	1,316	–	–	0.14%	27
2024 Q4	$234K	Hold	1,316	–	–	0.12%	32
2024 Q3	$260K	Hold	1,316	–	–	0.13%	29
2024 Q2	$226K	Hold	1,316	–	–	0.13%	31
2024 Q1	$240K	Hold	1,316	–	–	0.14%	29
2023 Q4	$204K	Buy	+1,316	New	+$192K	0.13%	50
2023 Q2	–	Sell	-1,316	Closed	-$210K	–	48
2023 Q1	$210K	Hold	1,316	–	–	0.18%	34
2022 Q4	$213K	Buy	+1,316	New	+$202K	0.2%	42

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

IMPACTfolio's ABBV Position: Q3 2026 in Review

IMPACTfolio held its AbbVie (ABBV) position steady in Q3 2026 at 1,761 shares worth $461K. The position accounts for 0.17% of the portfolio, ranked #23.

IMPACTfolio first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $488K in Q3 2025. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

IMPACTfolio held 1,761 shares of AbbVie worth $461K as of Q3 2026.
IMPACTfolio left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.17% of IMPACTfolio's portfolio in Q3 2026, its #23 holding.
IMPACTfolio first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
IMPACTfolio's AbbVie position peaked at $488K in Q3 2025.
1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on IMPACTfolio's 13F filing for Q3 2026, filed 28 Oct 2026.